IP Library › Assignment 054658/0567
Patent Assignment
Reel/Frame 054658/0567

Release of Security Interest

Recorded: 2020-12-15 Pages: 12
Assignor
KREOS CAPITAL V (UK) LIMITED
Executed: 2020-12-15
Assignee
MEREO BIOPHARMA 3 LIMITED
1 CAVENDISH PLACE, LONDON, W1G 0QF, UNITED KINGDOM
Covered Properties (3)
Compositions and Methods for Use for Antibodies Against Sclerostin
Patent: 7,879,322 →
Application: 12/249,050 →
Publication: US 2009/0130113
Compositions and Methods for Use for Antibodies Against Sclerostin
Patent: 8,246,953 →
Application: 12/944,019 →
Publication: US 2011/0052592
Polynucleotides Encoding Antibodies Against Sclerostin and Uses Therefor
Patent: 8,486,661 →
Application: 13/547,598 →
Publication: US 2012/0276591
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Change of Address May 23, 2018
From: MEREO BIOPHARMA 3 LIMITED
To: MEREO BIOPHARMA 3 LIMITED
Reel/Frame 047095/0330 →
Security Interest Nov 7, 2018
From: MEREO BIOPHARMA 3 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0701 →